Statistical significant heterogeneity among studies was observed in the association analysis between the EGF +61A/G polymorphism and gastric cancer risk in the overall populations (GG vs. AA: PQ = 0.074; GG vs. AG + AA: PQ = 0.048; Table 3). The gene discussed is EGF; the disease is gastric cancer.